A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients.

Authors:
Eslami S; Glassy MC; Ghafouri-Fard S.

Journal:
Gene

Publication Year: 2021

DOI:
10.1016/j.gene.2021.146113

PMCID:
PMC8656178

PMID:
34896524

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Gene

Abbreviation: Gene

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics.
Arman K; Dalloul Z; Bozgeyik E. (2023) - Transparency Score: 3/6
From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants.
Papanikolaou V; Chrysovergis A; Ragos V and 10 more (2022) - Transparency Score: 3/6
Human T-lymphotropic virus type 1 and novel coronavirus disease 2019; More complex than just a simp…
Sajjadi S; Hejazi S; Ravanshad S and 1 more (2022) - Transparency Score: 2/6
In silico analysis of genomic landscape of SARS-CoV-2 and its variant of concerns (Delta and Omicro…
Saini S; Khurana S; Saini D and 7 more (2022) - Transparency Score: 4/6
Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection.
Wang Z; Zhong K; Wang G and 10 more (2022) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"appendix a supplementary material the following are the supplementary data to this article: supplementary data 1 appendix a supplementary data to this article can be found online at https://doi org/10 1016/j gene 2021 146113 ."

Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025